What the labels report
On Wegovy, 1.4% had injection-site reactions (itching, redness, inflammation, hardening, irritation) against 1% on placebo.[1] On Zepbound it was 6%, 8% and 8% at 5, 10 and 15 mg, against 2%, including bruising, redness, itching, pain and rash. Hypersensitivity reactions of any kind were 5% versus 3% on Zepbound.[2]
What the labels say about sites
Both labels list the abdomen, thigh and upper arm as injection areas and say to rotate sites with each dose.[1][2] How to inject is something the prescriber or pharmacist should show you; this page is not a how-to.
Signs of an allergic reaction
- Swelling of the face, lips, tongue or throat
- Trouble breathing or swallowing
- Severe rash or itching over the body, a very fast heartbeat, fainting
These are the signs of a serious allergic reaction listed in the label, and need emergency care.[1] A spreading, hot, painful area with fever is a reason to be checked for infection.
The short version
Short on the way. A 35-second captioned version of this page is in production for the Fewer Bites channel. It will be embedded here when it is live.
Questions to bring to your prescriber
Print these or screenshot them. They are conversation starters, not a checklist of things to do.
- Can you or the pharmacist watch me inject once to check my technique?
- Is this reaction the kind that settles, or should we look at it?
Education, not advice. This page explains what trials, labels and guidelines report. It does not tell anyone to start, change or stop a medicine. Your prescriber knows your history; this page does not.
Sources
- Novo Nordisk / FDA. Wegovy (semaglutide) injection and tablets, prescribing information, revised 06/2026. label
- Eli Lilly / FDA. Zepbound (tirzepatide) prescribing information, revised 08/2026. label